About Yasmin Khera

This author has not yet filled in any details.
So far Yasmin Khera has created 35 blog entries.

Accelerating Vaccine Development Through Community-Based Pharmacy Clinical Infrastructure

Accelerating Vaccine Development Through Community-Based Pharmacy Clinical Infrastructure The partnership between WEP Clinical and RxE2 establishes a differentiated model for vaccine trial execution: one that leverages the accessibility of community pharmacies alongside global clinical [...]

By |2026-03-24T13:23:57+00:00February 27th, 2026|WEP Insights|

Designing Trials Families Can Say Yes To: Reducing Burden in Childhood Cancer Research

A WEP Clinical White Paper With Every Patient In Recognition of International Childhood Cancer Day - February 15 Executive Summary Scientific innovation in pediatric oncology has accelerated, yet clinical trial participation among children with cancer [...]

By |2026-02-17T12:44:22+00:00February 17th, 2026|WEP Insights|

Operationalizing the FDA’s Diversity in Clinical Trials Guidance Through Home Nursing Models

The FDA’s expectations around equitable access and representative enrollment in clinical research have moved from encouraged to operationally expected. With the FDA’s Enhancing Participation in Clinical Trials - Eligibility Criteria, Enrollment Practices, and Trial Designs final guidance (published December 15, [...]

By |2026-02-03T06:21:53+00:00February 2nd, 2026|WEP Insights|

The Evolution of Clinical Trials in the Modern Era: Advancing a Patient-First Model for Rare Disease and Oncology Development

A WEP Clinical White Paper With Every Patient Executive Summary Clinical trials have evolved significantly over the past several decades, driven by scientific innovation, regulatory modernization, and the increasing complexity of investigational therapies. Yet, despite [...]

By |2026-02-02T20:03:00+00:00January 29th, 2026|WEP Insights|

What The Latest U.S. FDA & Health Canada Updates Mean For Your Expanded Access Strategy in 2026

Over the past few months, both the United States FDA and Health Canada have updated their guidance on expanded / early access. Although these changes haven’t radically rewritten the rulebook, they have raised the bar [...]

By |2026-02-02T20:04:17+00:00December 12th, 2025|WEP Insights|

The Role of WEP’s Clinical Nursing Visit Coordinators in Ensuring Seamless Home Nursing Visits for Clinical Trials

At WEP Clinical, we offer comprehensive Mobile Nursing solutions for Sponsors, CROs, and clinical trial sites around the globe. Our mission is to ease the burdens placed on all study stakeholders by allowing patients to participate in [...]

By |2025-12-12T11:23:05+00:00November 26th, 2025|WEP Insights|